©2025 RXinsider | RXinsider Market Intelligence Group | 2025
A Breakdown of McKesson
The pharmacy operations supply chain contains many
companies that may be difficult to understand due to their size,
complexity, and dynamic M&A nature. The spirit of RXinsider’s
“Company Teardown” reports is to educate pharmacy
professionals, pharmacists, and pharmacy students on our
industry’s largest companies by simplifying, organizing, and
presenting publicly available information in a consistent and
organized format. Future Company Teardown reports will focus
on other complex companies including Cardinal Health, BD,
Cencora, Omnicell, RedSail, and others.
This McKesson Teardown report is independent and has not been
funded, reviewed, or edited by McKesson employees or company
representatives. All information in the following report is publicly
available. Company Teardown reports are training aids developed
for general education purposes and are biased toward presenting
the information we feel our pharmacy audience would find most
relevant. These reports may be incomplete, are general in nature,
and should not be used for making investing decisions. Please
refer to the McKesson website and 2024 annual report for details.
McKesson defines itself the following way: “McKesson is a
diversified healthcare services leader dedicated to advancing
health outcomes for patients everywhere. Their teams partner
with
biopharma
companies,
care
providers,
pharmacies,
manufacturers, governments, and others to deliver insights,
products, and services to help make quality care more accessible
and affordable.”
Table of Contents
• Introduction .................................................... 2-3
• Company Snapshot ..........................................4
• Strategic Initiatives ...........................................5
• McKesson History and Timeline ....................6
• Corporate Map (National) ................................7
• McKesson Division Breakdown .....................8
• McKesson Division Org Charts:
• U.S Pharmaceutical ....................................9
• Prescription Technology Serv. (RxTS) ...10
• Medical-Surgical ........................................12
• International ...............................................13
• McKesson Market Risks .........................14-15
• McKesson Ventures .......................................16
• Finance & Stock Performance ......................17
• Customers & Competition ............................18
• 2025 Conferences .........................................19
• References ......................................................20
• Pharmacy500 Companies .....................21-24